N.R. Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 2.65 Cr
- Company Age 27 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 97.40 Cr
- Satisfied Charges ₹ 10.82 Cr
- Revenue Growth 14.65%
- Profit Growth 8.60%
- Ebitda 14.31%
- Net Worth 13.02%
- Total Assets 31.34%
About N.R. Pharmaceuticals
N.R. Pharmaceuticals Private Limited (NPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 19 September 1997 and has a history of 27 years and five months. Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 2.65 Cr.
The company currently has active open charges totaling ₹97.40 Cr. The company has closed loans amounting to ₹10.82 Cr, as per Ministry of Corporate Affairs (MCA) records.
Dharmadas Mitra, Dulal Mitra, Jayeeta Mitra, and One other member serve as directors at the Company.
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24232WB1997PTC085495
- Company No.
085495
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Sep 1997
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at N.R. Pharmaceuticals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dulal Mitra  | Director | 19-Sep-1997 | Current |
| Dharmadas Mitra | Director | 19-Sep-1997 | Current |
| Jayeeta Mitra | Director | 26-Oct-2004 | Current |
| Saswati Mitra | Director | 26-Oct-2004 | Current |
Financial Performance of N.R. Pharmaceuticals.
N.R. Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 14.65% increase. The company also saw a slight improvement in profitability, with a 8.6% increase in profit. The company's net worth Soared by an impressive increase of 13.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of N.R. Pharmaceuticals?
In 2023, N.R. Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹97.40 Cr
₹10.82 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 59.76 Cr
- Others : 37.64 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Feb 2024 | Hdfc Bank Limited | ₹20.00 Cr | Open |
| 31 Jul 2023 | Hdfc Bank Limited | ₹39.29 Cr | Open |
| 26 Apr 2023 | Hdfc Bank Limited | ₹2.51 M | Open |
| 22 Mar 2023 | Others | ₹2.40 Cr | Open |
| 25 Nov 2022 | Hdfc Bank Limited | ₹2.19 M | Open |
How Many Employees Work at N.R. Pharmaceuticals?
N.R. Pharmaceuticals has a workforce of 137 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of N.R. Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped N.R. Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.